Fig. 6
From: Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Consensus recommendations for monitoring progression and defining treatment success in SSc-ILD. 6MWD 6-min walk distance; CPET cardiopulmonary exercise testing, DLCO diffusing capacity of the lungs for carbon monoxide, FVC forced vital capacity, HRCT high-resolution computed tomography, ILD interstitial lung disease, NYHA FC New York Heart Association Functional Classification, PFT pulmonary function test, SD standard deviation, SSc-ILD systemic sclerosis-associated ILD